SCHEMBL572646

SCHEMBL572646

CCCCCCCC(=O)NO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 1.00
HDAC3 O15379 2/20 0.75
HDAC1 Q13547 2/20 0.75
HDAC2 Q92769 2/20 0.75
HDAC8 Q9BY41 2/20 0.75
HDAC6 Q9UBN7 2/20 0.75
HDAC5 Q9UQL6 1/20 0.75
FAAH O00519 4/20 0.64
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
MAPK1 P28482 1/20 0.59
CES2 O00748 3/20 0.56
CES1 P23141 3/20 0.56
PPARG P37231 4/20 0.54
PPARD Q03181 4/20 0.54
PPARA Q07869 4/20 0.54
TSHR P16473 3/20 0.54
GPR84 Q9NQS5 3/20 0.54
HDAC11 Q96DB2 3/20 0.54
ALDH1A1 P00352 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2403692 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL1290964 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL331039 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL4155670 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL7945790 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL23203038 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL5575814 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL20915286 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL20602650 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8
SCHEMBL8977849 1.00 HSP90AA1 (1.00) HSP90AA1HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2952 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144257-A1 VITAMIN B3 BASED PRESERVATIVE COMPOSITIONS SHARON PERSONAL CARE LTD. (IL) 2026-05-28 US claimed
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
EP-4743051-A1 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS Symrise AG (DE) 2026-05-20 EP claimed
EP-4734933-A1 COSMETIC COMPOSITION Unilever IP Holdings B.V. (NL) 2026-05-06 EP claimed
EP-4731736-A1 COMPOSITION COMPRISING BIOSURFACTANT AND MANGANESE Evonik Operations GmbH (DE) 2026-04-29 EP claimed
US-12583808-B2 Biobased alkyl glyceryl ethers and methods of making and using the same INOLEX INVESTMENT CORPORATION (US) 2026-03-24 US claimed
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SYMRISE AG (DE) 2026-03-17 US claimed
US-12576153-B2 Preservative systems ALUMIER LABS, INC. (CA) 2026-03-17 US claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
US-12569533-B2 Bruising and filler compositions and methods for use ALASTIN Skincare, Inc. (US) 2026-03-10 US claimed
US-20020068693-A1 A) somatotropin; b) a first bioavailability enhancing constituent, which is a nonionic surfactant or a cyclodextrin, and c) optionally, a second BEC UNION AGENER, INC. 2002-06-06 US claimed
WO-2002000261-A2 SURFACTANT-CONTAINING FORMULATIONS FOR EXTENDED RELEASE OF SOMATOTROPIN MONSANTO TECHNOLOGY LLC (US) 2002-01-03 WO claimed
EP-0598747-B1 N-ETHYL HYDROXAMIC ACID CHELANTS MET TECH SYSTEMS LTD (CA) 1996-04-24 EP claimed
US-5487842-A LOW VISCOSITY, RAPID PHASE SEPARATION, HYDROLYTIC STABILITY MET-TECH SYSTEMS LIMITED (CA) 1996-01-30 US claimed
US-5328626-A Extraction of metals from aqueous solutions MET-TECH SYSTEMS, LTD. (CA) 1994-07-12 US claimed
EP-0598747-A1 N-ETHYL HYDROXAMIC ACID CHELANTS. MONSANTO CO (US) 1994-06-01 EP claimed
WO-1993002047-A1 N-ETHYL HYDROXAMIC ACID CHELANTS MONSANTO COMPANY (US) 1993-02-04 WO claimed
US-5174917-A Compositions containing n-ethyl hydroxamic acid chelants MONSANTO COMPANY (US) 1992-12-29 US claimed
WO-1992016200-A1 THE USE OF HYDROXAMIC ACID DERIVATIVES TO INHIBIT VIRAL REPLICATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) 1992-10-01 WO claimed
EP-0253486-A1 Oral composition LION CORPORATION (JP) 1988-01-20 EP claimed